References
Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Bisceglie AD, Peters M, Waggoner JG, Park Y, Jones EA: Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 315:1575–1578, 1986
Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, The Hepatitis Interventional Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alpha, a multi-center randomized, controlled trial. N Engl J Med 321:1501–1506, 1989
Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M: Detection of hepatitis C virus RNA, by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 60:215–222, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamada, G., Takahashi, M., Tsuji, T. et al. Quantitative HCV RNA and effect of interferon therapy in chronic hepatitis C. Digest Dis Sci 37, 1926–1927 (1992). https://doi.org/10.1007/BF01308091
Issue Date:
DOI: https://doi.org/10.1007/BF01308091